Company intelligence / Profile preview

Tulavi Therapeutics

Los Gatos, California, United Statestulavi.com ↗

Ownership: Private
Development stage: Commercial

Overview

Tulavi’s lead product, allay™ Nerve Cap with Adaptive Hydrogel Technology, is the first fully absorbable in situ device designed to protect transected nerves and prevent neuroma formation. Preclinical animal studies have shown zero neuroma formation compared to controls. Additional pipeline products targeting adhesion reduction and transected nerve repair have also demonstrated strong preclinical efficacy with no adhesion or successful sciatic nerve repair in animal models. The company is currently awaiting its first FDA de novo clearance.

Therapeutic areas: Neurology
Modalities: DeviceHydrogel-based drug delivery therapyBiomaterial (Adaptive Hydrogel Technology)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

allay Nerve Cap

Commercial

Indications: Neuroma prevention, Nerve repair, Peripheral nerve injury

Partnerships

Ascension VenturesDelos CapitalIncept LLC

Beyond the preview

Go deeper on Tulavi Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tulavi Therapeutics.

Explore the full profile